5 Key Takeaways
-
1
The Calibreye system offers comparable pressure and medication reduction to existing drainage implants for glaucoma management.
-
2
A 12-month feasibility study showed that the laser-adjustable shunt allows safe modulation of outflow resistance post-implantation.
-
3
Among 31 eyes with complete follow-up, mean intraocular pressure (IOP) decreased by 35% from baseline, averaging 14.5 mmHg.
-
4
93.5% of patients were medication-free or using the same or fewer medications than at baseline after the procedure.
-
5
The adjustable resistance mechanism provides individualized pressure control and may help mitigate early hypotony.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.